Skip to main content

Ioversol Injection

Last Updated: January 8, 2023
Status: Current

Products Affected - Description
    • Optiray 300 solution for injection, Guerbet, 100 mL bottle, 12 count, NDC 00019-1332-11
    • Optiray 300 solution for injection, Guerbet, 100 mL prefilled syringe, 20 count, NDC 00019-1332-90
    • Optiray 300 solution for injection, Guerbet, 100 mL RFID technology prefilled syringe, NDC 00019-1332-00
    • Optiray 300 solution for injection, Guerbet, 200 mL bottle, 12 count, NDC 00019-1332-21
    • Optiray 300 solution for injection, Guerbet, 50 mL Hand Held prefilled syringe, 20 count, NDC 00019-1332-78
    • Optiray 300 solution for injection, Guerbet, 50 mL vial, 25 count, NDC 00019-1332-06
    • Optiray 300 solution for injection, Guerbet, 500 mL pharmacy bulk pack, multi-dose bottle, 6 count, NDC 00019-1332-61 - discontinued
    • Optiray 320 solution for injection, Guerbet, 100 mL bottle, 12 count, NDC 00019-1323-11
    • Optiray 320 solution for injection, Guerbet, 100 mL prefilled syringe, 20 count, NDC 00019-1323-90
    • Optiray 320 solution for injection, Guerbet, 100 mL RFID technology prefilled syringe, NDC 00019-1323-00
    • Optiray 320 solution for injection, Guerbet, 125 mL prefilled syringe, 20 count, NDC 00019-1323-87
    • Optiray 320 solution for injection, Guerbet, 125 mL RFID technology prefilled syringe, NDC 00019-1323-27
    • Optiray 320 solution for injection, Guerbet, 150 mL bottle, 12 count, NDC 00019-1323-16
    • Optiray 320 solution for injection, Guerbet, 20 mL vial, 25 count, NDC 00019-1323-02
    • Optiray 320 solution for injection, Guerbet, 200 mL bottle, 12 count, NDC 00019-1323-21
    • Optiray 320 solution for injection, Guerbet, 30 mL vial, 25 count, NDC 00019-1323-04 - discontinued
    • Optiray 320 solution for injection, Guerbet, 50 mL Hand Held prefilled syringe, 20 count, NDC 00019-1323-78
    • Optiray 320 solution for injection, Guerbet, 50 mL prefilled syringe, 20 count, NDC 00019-1323-52
    • Optiray 320 solution for injection, Guerbet, 50 mL vial, 25 count, NDC 00019-1323-06
    • Optiray 320 solution for injection, Guerbet, 500 mL pharmacy bulk pack, multi-dose bottle, 6 count, NDC 00019-1323-61 - discontinued
    • Optiray 320 solution for injection, Guerbet, 75 mL prefilled syringe, 20 count, NDC 00019-1323-95
    • Optiray 320 solution for injection, Guerbet, 75 mL RFID technology prefilled syringe, NDC 00019-1323-85
    • Optiray 350 solution for injection, Guerbet, 100 mL bottle, 12 count, NDC 00019-1333-11
    • Optiray 350 solution for injection, Guerbet, 100 mL prefilled syringe, 20 count, NDC 00019-1333-90
    • Optiray 350 solution for injection, Guerbet, 100 mL RFID technology prefilled syringe, NDC 00019-1333-00
    • Optiray 350 solution for injection, Guerbet, 125 mL prefilled syringe, 20 count, NDC 00019-1333-87
    • Optiray 350 solution for injection, Guerbet, 125 mL RFID technology prefilled syringe, NDC 00019-1333-27
    • Optiray 350 solution for injection, Guerbet, 150 mL bottle, 12 count, NDC 00019-1333-16
    • Optiray 350 solution for injection, Guerbet, 200 mL bottle, 12 count, NDC 00019-1333-21
    • Optiray 350 solution for injection, Guerbet, 50 mL Hand Held prefilled syringe, 20 count, NDC 00019-1333-78
    • Optiray 350 solution for injection, Guerbet, 50 mL prefilled syringe, 20 count, NDC 00019-1333-52 - discontinued
    • Optiray 350 solution for injection, Guerbet, 50 mL RFID technology prefilled syringe, NDC 00019-1333-55 - discontinued
    • Optiray 350 solution for injection, Guerbet, 50 mL vial, 25 count, NDC 00019-1333-06
    • Optiray 350 solution for injection, Guerbet, 500 mL pharmacy bulk pack, multi-dose bottle, 6 count, NDC 00019-1333-61 - discontinued
    • Optiray 350 solution for injection, Guerbet, 75 mL prefilled syringe, 20 count, NDC 00019-1333-95
Reason for the Shortage
    • Iohexol (Omnipaque - GE Healthcare) injection is currently in shortage due to the shutdown of a production facility in Shanghai, China during a COVID-19 lockdown. The facility is open again and production is operating at full capacity. As a result of the iohexol shortage, other contrast agents may be affected as organizations seek suitable alternatives.
    • Guerbet states Optiray is on back order due to a shortage of raw material.
Available Products
    • There are no presentations available.

Estimated Resupply Dates

    • Guerbet has Optiray 300 100 mL bottles on back order and the company estimates release dates of late-January 2023. All other Optiray 300 presentations are on back order and the company cannot estimate release dates.
    • Guerbet has Optiray 320 50 mL vials on back order and the company estimates a release date of late-January 2023. All other Optiray 320 presentations are on back order and the company cannot estimate release dates.
    • Guerbet has Optiray 350 125 mL power injector syringes on back order and the company estimates a release date of late-January 2023. Optiray 50 mL glass bottles are on back order and the company estimates a release date of late-January 2023. Optiray 350 150 mL and 200 mL bottles are on back order and the company estimates a release date of mid-January 2023. All other Optiray 350 mL presentations are on back order and the company cannot estimate release dates.

Alternative Agents & Management

Updated

Updated January 8, 2023 by Elyse MacDonald, PharmD, MS, BCPS. Created May 20, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.